{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:41:08Z","timestamp":1792698068885,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Huntington Association"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Genet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The literature provides limited evidence on the effectiveness of psychological interventions for individuals living with Huntington\u2019s Disease (HD). This study aims to examine the role of psychological support in improving the well-being of individuals and families affected by HD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study methodology builds on previous work conducted by the European Huntington Association (EHA). The study includes individuals across three categories: individuals at risk of HD, premanifest HD, or with an HD-negative genetic test. Eligible participants were offered eight online individual cognitive behavioural therapy (CBT) sessions followed by two group sessions. Assessments were performed at pre-intervention, after the individual sessions and after the group sessions. The primary outcomes were anxiety, depression, positive and negative affect, and quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-one individuals participated in the study, of whom 33% (n\u2009=\u20097) had an HD-negative genetic test, 29% (n\u2009=\u20096) were at risk, and 38% (n\u2009=\u20098) had premanifest HD; the cohort was 57% women (n\u2009=\u200912). Analyses showed significant reductions in depression and anxiety, with medium to large effect sizes. Negative affect also decreased significantly with a large effect, while positive affect showed a non-significant trend toward improvement. Quality-of-life outcomes (physical and mental health components) did not change significantly. Overall, the strongest effects were observed for mood-related outcomes (depression, anxiety, and negative affect).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our data shows that a short-term CBT intervention led to improvements in anxiety, depression and negative affect. These findings enhance the evidence base available supporting the efficacy of psychological interventions that may be beneficial for individuals affected by HD. The article also outlines key lessons regarding intervention tailoring and study design to inform future research exploring the efficacy of psychological interventions for this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12687-026-00923-6","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:04:14Z","timestamp":1788332654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychological interventions for individuals affected by Huntington\u2019s disease: effects on depression, anxiety, and emotional well-being"],"prefix":"10.1007","volume":"17","author":[{"given":"Andrada","family":"Ciuc\u0103","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0218tefan","family":"Trif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Samoil\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u0103d\u0103lina","family":"Radu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Iruela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica Rodr\u00edguez","family":"Lopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar Aguilera","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"J\u00falio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astri","family":"Arnesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6013-5076","authenticated-orcid":false,"given":"Ramona","family":"Moldovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"1","key":"923_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3233\/jhd-2012-120002","volume":"1","author":"LEI A\u2019Campo","year":"2012","unstructured":"A\u2019Campo LEI, Spliethoff-Kamminga NGA, Roos RAC (2012) The Patient Education Program for Huntington\u2019s Disease (PEP-HD). J Huntington\u2019s Disease 1(1):47\u201356. https:\/\/doi.org\/10.3233\/jhd-2012-120002","journal-title":"J Huntington\u2019s Disease"},{"issue":"10","key":"923_CR3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/ejhg.2016.36","volume":"24","author":"SS Baig","year":"2016","unstructured":"Baig SS, Strong M, Rosser E, Taverner NV, Glew R, Miedzybrodzka Z, Clarke A, Craufurd D, Quarrell OW (2016) 22 Years of predictive testing for Huntington\u2019s disease: the experience of the UK Huntington\u2019s Prediction Consortium. Eur J Hum Genet 24(10):1396\u20131402. https:\/\/doi.org\/10.1038\/ejhg.2016.36","journal-title":"Eur J Hum Genet"},{"key":"923_CR5","doi-asserted-by":"crossref","unstructured":"Bates G, Tabrizi S, Jones L (2014) Huntington\u2019s disease. Oxford University Press","DOI":"10.1093\/med\/9780199929146.001.0001"},{"issue":"2","key":"923_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1037\/rep0000311","volume":"65","author":"NR Boileau","year":"2020","unstructured":"Boileau NR, Paulsen JS, Ready RE, Hahn EA, Lai JS, Carlozzi NE (2020) Understanding domains that influence perceived stigma in individuals with Huntington disease. Rehabil Psychol 65(2):113\u2013121. https:\/\/doi.org\/10.1037\/rep0000311","journal-title":"Rehabil Psychol"},{"issue":"1","key":"923_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10897-014-9755-y","volume":"24","author":"S Crozier","year":"2014","unstructured":"Crozier S, Robertson N, Dale M (2014) The Psychological Impact of Predictive Genetic Testing for Huntington\u2032s Disease: A Systematic Review of the Literature. J Genet Couns 24(1):29\u201339. https:\/\/doi.org\/10.1007\/s10897-014-9755-y","journal-title":"J Genet Couns"},{"issue":"4","key":"923_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1176\/appi.neuropsych.14100265","volume":"27","author":"M Dale","year":"2015","unstructured":"Dale M, van Duijn E (2015) Anxiety in Huntington\u2019s Disease. J Neuropsychiatry Clin Neurosci 27(4):262\u2013271. https:\/\/doi.org\/10.1176\/appi.neuropsych.14100265","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"923_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/sj.ejhg.5200913","volume":"11","author":"M Decruyenaere","year":"2003","unstructured":"Decruyenaere M, Evers-Kiebooms G, Cloostermans T, Boogaerts A, Demyttenaere K, Dom R, Fryns JP (2003) Psychological distress in the 5-year period after predictive testing for Huntington\u2019s disease. Eur J Hum Genet 11(1):30\u201338. https:\/\/doi.org\/10.1038\/sj.ejhg.5200913","journal-title":"Eur J Hum Genet"},{"key":"923_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00081","author":"X Du","year":"2013","unstructured":"Du X, Pang TYC, Hannan AJ (2013) A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington\u2019s Disease Gene Mutation. Front Neurol. 4https:\/\/doi.org\/10.3389\/fneur.2013.00081","journal-title":"Front Neurol"},{"key":"923_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/B978-0-12-801893-4.00011-0","volume":"144","author":"Erik van Duijn","year":"2017","unstructured":"Erik van Duijn (2017) Medical treatment of behavioral manifestations of Huntington disease. Handb Clin Neurol 144:129\u2013139","journal-title":"Handb Clin Neurol"},{"key":"923_CR43","unstructured":"European Huntington Association (n.d.). Huntington Academy: Real-life experiences for better care. academy.org\/ https:\/\/huntington-academy.org\/"},{"key":"923_CR12","doi-asserted-by":"crossref","unstructured":"Gunn S, Dale M, Ovaska-Stafford N, Maltby J (2023) Mental health symptoms among those affected by Huntington\u2019s disease: a cross-sectional study","DOI":"10.1002\/brb3.2954"},{"issue":"8","key":"923_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/jmg.37.8.567","volume":"37","author":"PS Harper","year":"2000","unstructured":"Harper PS (2000) Ten years of presymptomatic testing for Huntington\u2019s disease: the experience of the UK Huntington\u2019s Disease Prediction Consortium. J Med Genet 37(8):567\u2013571. https:\/\/doi.org\/10.1136\/jmg.37.8.567","journal-title":"J Med Genet"},{"key":"923_CR14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/mds.22412","volume":"24","author":"AK Ho","year":"2009","unstructured":"Ho AK, Gilbert AS, Mason SL, Goodman AO, Barker RA (2009) Health related quality of life in HD: Which factors matter most? Mov Disord 24:574\u2013578. https:\/\/doi.org\/10.1002\/mds.22412","journal-title":"Mov Disord"},{"issue":"8","key":"923_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/jpm11080815","volume":"11","author":"F J\u00falio","year":"2021","unstructured":"J\u00falio F, Blanco R, Casanova JP, D\u2019Alessio B, De Schepper B, De Sousa D, De Sousa P, Ferreira C, Gommans H, Haselberg R, Hermant E, Lis D, Maffi S, Olsen SO, Papantoniou M, Squitieri F, Tretyakova M, Umakhanova Z, V\u00e1clav\u00edk V, Winkelmann M (2021) Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington\u2019s Disease: A Survey Conducted by the European Huntington Association. J personalized Med 11(8):815. https:\/\/doi.org\/10.3390\/jpm11080815. On Behalf Of The European Huntington Association","journal-title":"J personalized Med"},{"issue":"9","key":"923_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9: Validity of a Brief Depression Severity Measure. J Gen Intern Med 16(9):606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"issue":"4","key":"923_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1212\/wnl.53.4.801","volume":"53","author":"F Laccone","year":"1999","unstructured":"Laccone F, Engel U, Holinski\u2013Feder E, Weigell\u2013Weber M, Marczinek K, Nolte D, Morris\u2013Rosendahl DJ, Z\u00fchlke C, Fuchs K, Weirich\u2013Schwaiger H, Schl\u00fcter G, von Beust G, Vieira\u2013Saecker AMM, Weber BHF, Riess O (1999) DNA analysis of Huntington\u2019s disease. Neurology 53(4):801\u2013801. https:\/\/doi.org\/10.1212\/wnl.53.4.801","journal-title":"Neurology"},{"issue":"2","key":"923_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/jhd-170276","volume":"7","author":"R MacLeod","year":"2018","unstructured":"MacLeod R, Moldovan R, Stopford C, Ferrer-Duch M (2018) Genetic Counselling and Narrative Practices: A Model of Support following a Negative Predictive Test for Huntington\u2019s Disease. J Huntington\u2019s Disease 7(2):175\u2013183. https:\/\/doi.org\/10.3233\/jhd-170276","journal-title":"J Huntington\u2019s Disease"},{"issue":"1","key":"923_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13023-023-02622-8","volume":"18","author":"A M\u00fchlb\u04d3ck","year":"2023","unstructured":"M\u00fchlb\u04d3ck A, van Walsem M, Nance M, Arnesen A, Page K, Fisher A, van Kampen M, Nuzzi A, Limpert R, Fossmo HL, Cruickshank T, Veenhuizen R, Multidisciplinary Care and Treatment Working Group of the European Huntington\u2019s Disease Network (2023) What we don\u2019t need to prove but need to do in multidisciplinary treatment and care in Huntington\u2019s disease: a position paper. Orphanet J Rare Dis 18(1):19. https:\/\/doi.org\/10.1186\/s13023-023-02622-8","journal-title":"Orphanet J Rare Dis"},{"key":"923_CR20","doi-asserted-by":"publisher","first-page":"111023","DOI":"10.1016\/j.jpsychores.2022.111023","volume":"162","author":"AC Ogilvie","year":"2022","unstructured":"Ogilvie AC, Carnahan RM, Chrischilles EA, Schultz JL (2022) The effects of antidepressants on depressive symptoms in manifest Huntington\u2019s disease. J Psychosom Res 162:111023. https:\/\/doi.org\/10.1016\/j.jpsychores.2022.111023","journal-title":"J Psychosom Res"},{"key":"923_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jad.2019.03.063","volume":"252","author":"J Osma","year":"2019","unstructured":"Osma J, Quilez-Orden A, Suso-Ribera C, Peris-Baquero O, Norman SB, Bentley KH, Sauer-Zavala S (2019) Psychometric properties and validation of the Spanish versions of the overall anxiety and depression severity and impairment scales. J Affect Disord 252:9\u201318. https:\/\/doi.org\/10.1016\/j.jad.2019.03.063","journal-title":"J Affect Disord"},{"key":"923_CR22","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1007\/s00415-022-11551-8","volume":"270","author":"W Pearl, Frank","year":"2023","unstructured":"Pearl, Frank W, Heemskerk A-W, van Duijn E, M\u00fchlb\u00e4ck A, Landwehrmeyer GB, Chavannes NH, Meijer E, Chavannes NH, Pearl S, Landwehrmeyer GB, Steck F, Klemp\u00ed\u0159 J, Konvalinkov\u00e1 R, Bezuchov\u00e1 E, Dole\u010dkov\u00e1 K, Klemp\u00ed\u0159ov\u00e1 O, Roth J (2023) Quality of life, health-related quality of life, and associated factors in Huntington\u2019s disease: a systematic review. J Neurol 270:2416\u20132437. https:\/\/doi.org\/10.1007\/s00415-022-11551-8","journal-title":"J Neurol"},{"issue":"4","key":"923_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/18796397241288449","volume":"13","author":"B Pires","year":"2024","unstructured":"Pires B, Kunkel S, Goodwin D, Dace N, Culliford S, Kipps D, C., Portillo MC (2024) Are people living with Huntington\u2019s disease experiencing person-centered integrated care? J Huntington\u2019s Disease 13(4):535\u2013546. https:\/\/doi.org\/10.1177\/18796397241288449","journal-title":"J Huntington\u2019s Disease"},{"issue":"1","key":"923_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21500\/20112084.3745","volume":"12","author":"GG Reivan-Ortiz","year":"2019","unstructured":"Reivan-Ortiz GG, Pineda-Garcia G, Le\u00f3n Parias BD (2019) Psychometric Properties of The Goldberg Anxiety and Depression Scale (GADS) In Ecuadorian Population. Int J Psychol Res 12(1):41\u201348. https:\/\/doi.org\/10.21500\/20112084.3745","journal-title":"Int J Psychol Res"},{"issue":"1","key":"923_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5944\/rppc.8.num.1.2003.3941","volume":"8","author":"B Sand\u00edn","year":"2003","unstructured":"Sand\u00edn B, Chorot P (2003) Cuestionario de afrontamiento del estr\u00e9s (CAE): desarrollo y validaci\u00f3n preliminar. Revista de Psicopatolog\u00eda y Psicolog\u00eda Cl\u00ednica 8(1):39\u201353. https:\/\/doi.org\/10.5944\/rppc.8.num.1.2003.3941","journal-title":"Revista de Psicopatolog\u00eda y Psicolog\u00eda Cl\u00ednica"},{"issue":"2","key":"923_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s0738-3991(02)00070-8","volume":"49","author":"A Silver","year":"2003","unstructured":"Silver A (2003) Cognitive-behavioural therapy with a Huntington\u2019s gene positive patient. Patient Educ Couns 49(2):133\u2013138. https:\/\/doi.org\/10.1016\/s0738-3991(02)00070-8","journal-title":"Patient Educ Couns"},{"key":"923_CR27","doi-asserted-by":"publisher","unstructured":"Spiers J, Smith JA, Ferrer-Duch M, Moldovan R, Roche J, MacLeod R (2020) Evaluating a genetic counseling narrative group session for people who have tested positive for the Huntington\u2019s disease expansion: An interpretative phenomenological analysis. J Genet Couns 29(6). https:\/\/doi.org\/10.1002\/jgc4.1229","DOI":"10.1002\/jgc4.1229"},{"issue":"10","key":"923_CR28","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B (2006) A Brief Measure for Assessing Generalized Anxiety disorder: the GAD-7. Arch Intern Med 166(10):1092\u20131097. https:\/\/doi.org\/10.1001\/archinte.166.10.1092","journal-title":"Arch Intern Med"},{"issue":"1","key":"923_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12687-019-00416-9","volume":"11","author":"C Stopford","year":"2019","unstructured":"Stopford C, Ferrer-Duch M, Moldovan R, MacLeod R (2019) Improving follow up after predictive testing in Huntington\u2019s disease: evaluating a genetic counselling narrative group session. J Community Genet 11(1):47\u201358. https:\/\/doi.org\/10.1007\/s12687-019-00416-9","journal-title":"J Community Genet"},{"issue":"2","key":"923_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/ph17020151","volume":"17","author":"AD Teuntje","year":"2024","unstructured":"Pelgrim T, Philipsen A, Young AH, Juruena M, Jimenez E, Vieta E, Juki\u0107 M, Van E, Heilbronner U, Moldovan R, Jagesar MRR, N\u00f6then MM, Hoffmann P, Shomron N, Kilarski LL, van Amelsvoort T, Campforts B, van Westrhenen R (2024) A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study. Pharmaceuticals 17(2):151\u2013151. https:\/\/doi.org\/10.3390\/ph17020151","journal-title":"Pharmaceuticals"},{"issue":"2","key":"923_CR31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/papt.12157","volume":"91","author":"R Theed","year":"2017","unstructured":"Theed R, Eccles FJR, Simpson J (2017) Understandings of psychological difficulties in people with the Huntington\u2019s disease gene and their expectations of psychological therapy. Psychol Psychotherapy: Theory Res Pract 91(2):216\u2013231. https:\/\/doi.org\/10.1111\/papt.12157","journal-title":"Psychol Psychotherapy: Theory Res Pract"},{"key":"923_CR32","doi-asserted-by":"publisher","unstructured":"Tiller\u00e5s KH, Kjoelaas SH, Dramstad E, Feragen KB, Lippe C (2020) Psychological reactions to predictive genetic testing for Huntington\u2019s disease: A qualitative study. J Genet Couns 29(6). https:\/\/doi.org\/10.1002\/jgc4.1245","DOI":"10.1002\/jgc4.1245"},{"issue":"1","key":"923_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s13023-024-03461-x","volume":"19","author":"PJC van Lonkhuizen","year":"2024","unstructured":"van Lonkhuizen PJC, Heemskerk AW, Slutter L, van Duijn E, de Bot ST, Chavannes NH, Meijer E, HEALTHE-RND consortium (2024) Shifting focus from ideality to reality: a qualitative study on how quality of life is defined by premanifest and manifest Huntington\u2019s disease gene expansion carriers. Orphanet J Rare Dis 19(1):444. https:\/\/doi.org\/10.1186\/s13023-024-03461-x","journal-title":"Orphanet J Rare Dis"},{"issue":"94","key":"923_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fpsyt.2020.00094","volume":"11","author":"R van Westrhenen","year":"2020","unstructured":"van Westrhenen R, Aitchison KJ, Ingelman-Sundberg M, Juki\u0107 MM (2020) Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going? Front Psychiatry 11(94):94. https:\/\/doi.org\/10.3389\/fpsyt.2020.00094","journal-title":"Front Psychiatry"},{"key":"923_CR35","unstructured":"Verdugo MA, Arias B, G\u00f3mez LE y, Schalock RL (2009) Escala Integral de Calidad de Vida. Madrid: CEPE"},{"issue":"3","key":"923_CR36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware","year":"1996","unstructured":"Ware J, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220\u2013233. https:\/\/doi.org\/10.1097\/00005650-199603000-00003","journal-title":"Med Care"},{"key":"923_CR37","unstructured":"Watson D, Clark AL, Tellegen A (1988) APA PsycNet. Psycnet.apa.org. https:\/\/psycnet.apa.org\/record\/1988-31508-001"},{"issue":"9734","key":"923_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/s0140-6736(10)60957-9","volume":"376","author":"A Wexler","year":"2010","unstructured":"Wexler A (2010) Stigma, history, and Huntington\u2019s disease. Lancet (London England) 376(9734):18\u201319. https:\/\/doi.org\/10.1016\/s0140-6736(10)60957-9","journal-title":"Lancet (London England)"},{"issue":"6","key":"923_CR39","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1007\/s10897-018-0257-1","volume":"27","author":"E Winnberg","year":"2018","unstructured":"Winnberg E, Winnberg U, Pohlkamp L, Hagberg A (2018) What to Do with a Second Chance in Life? Long-Term Experiences of Non-carriers of Huntington\u2019s Disease. J Genet Couns 27(6):1438\u20131446. https:\/\/doi.org\/10.1007\/s10897-018-0257-1","journal-title":"J Genet Couns"},{"key":"923_CR25","doi-asserted-by":"publisher","unstructured":"Zadegan SA, Ramirez F, Park JW, Rocha NP, Stimming EF, Teixeira AL (2024a) Frequency of depression in Huntington\u2019s disease: A systematic review and meta-analysis. J Huntingt S Disease 14(1). https:\/\/doi.org\/10.1177\/18796397241301774","DOI":"10.1177\/18796397241301774"},{"issue":"3","key":"923_CR40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/jhd-200418","volume":"9","author":"N Zarotti","year":"2020","unstructured":"Zarotti N, Dale M, Eccles F, Simpson J (2020) Psychological Interventions for People with Huntington\u2019s Disease: A Call to Arms. J Huntington\u2019s Disease 9(3):231\u2013243. https:\/\/doi.org\/10.3233\/jhd-200418","journal-title":"J Huntington\u2019s Disease"},{"issue":"2","key":"923_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/neurosci5020007","volume":"5","author":"N Zarotti","year":"2024","unstructured":"Zarotti N, D\u2019Alessio B, Scocchia M, Casella M, Squitieri F (2024) I Wouldn\u2019t Even Know What to Ask for: Patients\u2019 and Caregivers\u2019 Experiences of Psychological Support for Huntington\u2019s Disease in Italy. NeuroSci 5(2):98\u2013113. https:\/\/doi.org\/10.3390\/neurosci5020007","journal-title":"NeuroSci"}],"container-title":["Journal of Community Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-026-00923-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12687-026-00923-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-026-00923-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:02:10Z","timestamp":1792695730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12687-026-00923-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["923"],"URL":"https:\/\/doi.org\/10.1007\/s12687-026-00923-6","relation":{},"ISSN":["1868-6001"],"issn-type":[{"value":"1868-6001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"103"}}